72.61
price up icon0.06%   0.04
after-market アフターアワーズ: 72.61
loading
前日終値:
$72.57
開ける:
$72.59
24時間の取引高:
2.15M
Relative Volume:
0.46
時価総額:
$11.39B
収益:
$1.21B
当期純損益:
$109.52M
株価収益率:
104.29
EPS:
0.6962
ネットキャッシュフロー:
$269.60M
1週間 パフォーマンス:
+0.33%
1か月 パフォーマンス:
+0.39%
6か月 パフォーマンス:
+37.81%
1年 パフォーマンス:
+43.84%
1日の値動き範囲:
Value
$72.56
$72.64
1週間の範囲:
Value
$72.44
$72.69
52週間の値動き範囲:
Value
$43.20
$72.69

Bio Techne Corp Stock (TECH) Company Profile

Name
名前
Bio Techne Corp
Name
セクター
Healthcare (1067)
Name
電話
612-379-8854
Name
住所
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Name
職員
3,100
Name
Twitter
@biotechne
Name
次回の収益日
2026-11-04
Name
最新のSEC提出書
Name
TECH's Discussions on Twitter

Compare TECH vs VRTX, REGN, MRNA, ARGX, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
TECH icon
TECH
Bio Techne Corp
72.61 11.39B 1.21B 109.52M 269.60M 0.6962
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
526.19 133.37B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
788.04 81.13B 14.92B 4.42B 3.79B 41.04
MRNA icon
MRNA
Moderna Inc
198.88 79.40B 2.23B -3.19B -1.60B -8.1462
ARGX icon
ARGX
Argen X Se Adr
959.49 60.03B 4.16B 1.29B 734.26M 19.58
RVMD icon
RVMD
Revolution Medicines Inc
204.97 43.93B 742.00K -1.37B -1.07B -7.0731

Bio Techne Corp Stock (TECH) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-09-03 アップグレード RBC Capital Mkts Sector Perform → Outperform
2025-08-21 アップグレード Citigroup Neutral → Buy
2025-07-22 再開されました Stephens Overweight
2025-07-09 開始されました TD Cowen Buy
2025-05-30 開始されました Wells Fargo Overweight
2025-04-09 ダウングレード KeyBanc Capital Markets Overweight → Sector Weight
2025-03-18 開始されました Evercore ISI Outperform
2025-02-19 ダウングレード Robert W. Baird Outperform → Neutral
2024-05-22 ダウングレード Citigroup Buy → Neutral
2024-02-08 開始されました Scotiabank Sector Outperform
2024-02-02 ダウングレード Stifel Buy → Hold
2023-12-07 開始されました UBS Buy
2023-08-28 開始されました William Blair Outperform
2023-01-10 アップグレード Wells Fargo Underweight → Equal Weight
2022-12-14 開始されました Deutsche Bank Buy
2022-12-12 アップグレード Citigroup Neutral → Buy
2022-12-07 開始されました RBC Capital Mkts Sector Perform
2022-08-25 開始されました Credit Suisse Outperform
2022-04-25 ダウングレード Wells Fargo Equal Weight → Underweight
2021-09-15 アップグレード KeyBanc Capital Markets Sector Weight → Overweight
2021-03-08 アップグレード Stephens Equal-Weight → Overweight
2021-02-23 アップグレード Stifel Hold → Buy
2021-01-25 繰り返されました The Benchmark Company Buy
2020-11-10 開始されました KeyBanc Capital Markets Sector Weight
2020-09-30 開始されました Atlantic Equities Overweight
2020-07-15 ダウングレード Stephens Overweight → Equal-Weight
2020-05-27 ダウングレード Stifel Buy → Hold
2020-05-14 開始されました The Benchmark Company Buy
2020-01-08 再開されました Stephens Overweight
2020-01-08 開始されました Wells Fargo Equal Weight
2020-01-07 開始されました Citigroup Neutral
2019-11-15 開始されました Stifel Buy
2019-07-02 アップグレード Janney Neutral → Buy
2019-01-14 アップグレード Stephens Equal-Weight → Overweight
2018-10-31 ダウングレード Craig Hallum Buy → Hold
2018-10-17 開始されました Goldman Neutral
2018-06-15 開始されました Argus Buy
2017-07-13 開始されました Wells Fargo Market Perform
2017-02-09 開始されました Citigroup Buy
2017-01-18 開始されました Deutsche Bank Buy
2016-11-10 再開されました Leerink Partners Outperform
2015-01-21 繰り返されました Robert W. Baird Outperform
2013-09-20 アップグレード Robert W. Baird Neutral → Outperform
すべてを表示

Bio Techne Corp (TECH) 最新ニュース

pulisher
Sep 25, 2026

Bio-Techne (TECH) Shareholders Approve the Merck KGaA Takeover and Reject the Pay Package - Insider Monkey

Sep 25, 2026
pulisher
Sep 25, 2026

Robert V Baumgartner Exercises Options, Realizes $754K - Benzinga

Sep 25, 2026
pulisher
Sep 25, 2026

What Does Bio-Techne Corporation's (TECH) Latest Move Mean for Midcap Stocks Investors? - Kalkine Media

Sep 25, 2026
pulisher
Sep 25, 2026

Form 4 Bio-Techne Corp For: 25 September - Investing.com India

Sep 25, 2026
pulisher
Sep 25, 2026

Form 4 Bio-Techne Corp For: 25 September By Investing.com - Investing.com South Africa

Sep 25, 2026
pulisher
Sep 24, 2026

Bio-Techne (TECH) director exercises options and delivers or withholds 5,559 shares for costs or taxes. - Stock Titan

Sep 24, 2026
pulisher
Sep 24, 2026

Bio-Techne shareholders approve $11.3 billion merger with German Merck - AKM.RU

Sep 24, 2026
pulisher
Sep 24, 2026

What Does Shareholder Approval Mean for Bio-Techne's (NASDAQ:TECH) Merck KGaA Deal? - Kalkine Media

Sep 24, 2026
pulisher
Sep 24, 2026

Is Bio-Techne Stock Outperforming the Nasdaq? - barchart.com

Sep 24, 2026
pulisher
Sep 23, 2026

Form 8K Bio-Techne Corp For: 23 September By Investing.com - Investing.com Canada

Sep 23, 2026
pulisher
Sep 23, 2026

Form 8K Bio-Techne Corp For: 23 September - Investing.com India

Sep 23, 2026
pulisher
Sep 23, 2026

Merck KGaA's USD 11.3b Bio-Techne acquisition clears final shareholder approval hurdle - AllSci

Sep 23, 2026
pulisher
Sep 23, 2026

Bio-Techne (TECH) Opens Düsseldorf Hub As Fair Value Questions Come Into Focus - simplywall.st

Sep 23, 2026
pulisher
Sep 23, 2026

Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany - Investing News Network

Sep 23, 2026
pulisher
Sep 23, 2026

Bio-Techne shareholders approve Merck KGaA acquisition - Investing.com

Sep 23, 2026
pulisher
Sep 23, 2026

Bio-Techne Shareholders Approve Takeover by Merck KGaA - marketscreener.com

Sep 23, 2026
pulisher
Sep 22, 2026

Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration - Investing News Network

Sep 22, 2026
pulisher
Sep 22, 2026

Bio-Techne Opens New Customer Experience Center in Germany - marketscreener.com

Sep 22, 2026
pulisher
Sep 22, 2026

Bio-Techne opens customer experience center in Düsseldorf - Investing.com

Sep 22, 2026
pulisher
Sep 21, 2026

Bio-Techne Corp (TECH) Investor Outlook: Navigating Market Dynamics with a Focus on Growth Potential - DirectorsTalk Interviews

Sep 21, 2026
pulisher
Sep 21, 2026

Ademi LLP investigates Bio-Techne sale to Merck KGaA - scanx.trade

Sep 21, 2026
pulisher
Sep 17, 2026

Bio-Techne Corporation (TECH) Options ChainYahoo Finance - Yahoo! Finance Canada

Sep 17, 2026
pulisher
Sep 14, 2026

Bio-Techne issues supplemental merger disclosures amid shareholder lawsuit - Investing.com

Sep 14, 2026
pulisher
Sep 14, 2026

Form 8K Bio-Techne Corp For: 14 September By Investing.com - Investing.com Nigeria

Sep 14, 2026
pulisher
Sep 14, 2026

Bio-Techne supplements proxy disclosures after shareholder suit, seeks shareholder vote on Sept. 23 - TradingView

Sep 14, 2026
pulisher
Sep 11, 2026

Why Is Techne (TECH) Down 0.1% Since Last Earnings Report? - Eastern Progress

Sep 11, 2026
pulisher
Sep 10, 2026

TECH: Bio-Techne Corp Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

Sep 10, 2026
pulisher
Sep 09, 2026

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger – AUUD, TECH, CZR and CBAN - GlobeNewswire Inc.

Sep 09, 2026
pulisher
Sep 08, 2026

Research Use Recombinant Protein Market Report Now Available — Forecasts Market Growth from $1.11B (2026) to $1.55B by 2031, Profiling Thermo Fisher, Bio-Techne, Merck KGaA, Danaher, Revvity, and Others - Yahoo Finance UK

Sep 08, 2026
pulisher
Sep 08, 2026

IVD Raw Material Market Report Now Available — Forecasts Market Growth from $21.5B (2026) to $31.1B by 2031, Profiling Merck KGaA, Thermo Fisher, Bio-Techne, Fapon Biotech, and 21 Other Key Players - Yahoo Finance

Sep 08, 2026
pulisher
Sep 07, 2026

Bio-Techne Corp (TECH) Stock Analysis: Navigating Its Current Valuation and Growth Potential - DirectorsTalk Interviews

Sep 07, 2026
pulisher
Sep 04, 2026

Bio-Techne Corp (NASDAQ: TECH) Share Price, TECH Stock News, TECH Share Price & Updates - Kalkine

Sep 04, 2026
pulisher
Sep 04, 2026

Global Multiplex Assays Market 2026 Edition - GlobeNewswire Inc.

Sep 04, 2026
pulisher
Sep 04, 2026

Bio-Techne Corp (TECH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Sep 04, 2026
pulisher
Sep 02, 2026

Bio-Techne (TECH), What Is Behind The Latest Attention? - simplywall.st

Sep 02, 2026
pulisher
Sep 01, 2026

Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals - Investing News Network

Sep 01, 2026
pulisher
Aug 31, 2026

Legal & General buys $19.51M stake in Bio-Techne - app.dealroom.co

Aug 31, 2026
pulisher
Aug 31, 2026

Bio-Techne Corp (TECH) Stock Analysis: Evaluating the Balance Between Growth Potential and Current Valuation - DirectorsTalk Interviews

Aug 31, 2026
pulisher
Aug 28, 2026

Bio-Techne Corp (TECH) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research

Aug 28, 2026
pulisher
Aug 28, 2026

Bio-Techne To Be Acquired by Merck KGaA - Morningstar

Aug 28, 2026
pulisher
Aug 24, 2026

Bio-Techne draws fresh institutional cash as revenue climbs to $321M - app.dealroom.co

Aug 24, 2026
pulisher
Aug 24, 2026

BIO-TECHNE Corp FY 2026: Revenue $1.22B, EPS $1.16— 10-K Summary - TradingView

Aug 24, 2026
pulisher
Aug 21, 2026

Bio-Techne Gives FTC More Time On $11.3B Merck Deal - Law360

Aug 21, 2026
pulisher
Aug 21, 2026

Is Bio-Rad a Buy as Digital PCR Growth Meets a Premium Valuation? - TradingView

Aug 21, 2026
pulisher
Aug 21, 2026

Bio-Techne (TECH) Momentum: Adds 0.06% to Close at $72.32 in the Current Update; Price Context: the Current Price Sits Inside the Supplied Technical Range on the DayHedge Fund Favorites - careplusvn.com

Aug 21, 2026
pulisher
Aug 20, 2026

Bio-Techne (Nasdaq: TECH) investors to vote on Merck cash takeover - Stock Titan

Aug 20, 2026
pulisher
Aug 20, 2026

Bio-Techne (TECH) Quarterly Results: EPS Does Not Reach the Reported Estimate in Latest Trading; Price Reaction - careplusvn.com

Aug 20, 2026
pulisher
Aug 19, 2026

Bio-Techne (NASDAQ: TECH) GC gets new RSU grants, no stock sales - Stock Titan

Aug 19, 2026
pulisher
Aug 19, 2026

Bio-Techne (NASDAQ: TECH) grants CFO 22,438 and 36,459 RSUs - Stock Titan

Aug 19, 2026
pulisher
Aug 19, 2026

Bio-Techne (TECH) director granted 1,381 RSUs vesting 2027-29 - Stock Titan

Aug 19, 2026

Bio Techne Corp (TECH) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$117.83
price down icon 3.06%
$35.80
price down icon 0.91%
$58.21
price down icon 0.14%
$255.96
price up icon 2.55%
ONC ONC
$360.85
price up icon 0.24%
$204.97
price up icon 2.56%
大文字化:     |  ボリューム (24 時間):